The Serum Institute of India is a leading biotechnology company headquartered in Pune, India. Established in 1966 by Dr. Cyrus Poonawalla, the institute is renowned for producing high-quality vaccines that cater to global healthcare needs. It stands as the world’s largest vaccine manufacturer by doses, supplying over 1.5 billion doses annually. The company is particularly recognized for its extensive range of vaccines for diseases like polio, measles, and more recently, COVID-19.
The Serum Institute’s commitment to affordable healthcare is evident in its pricing strategy, allowing vaccines to reach underserved populations. Alongside its impressive production capabilities, the company’s research and development focus has led to collaborations with global health organizations and partnerships with major pharmaceutical firms. The Serum Institute of India logo symbolizes its dedication to innovation and public health.
Over the decades, the Serum Institute has played a pivotal role in immunization programs across various countries, helping to combat infectious diseases effectively. Its robust supply chain and adherence to quality standards ensure that vaccines are both safe and efficacious, making a significant impact on global health initiatives. As it continues to expand its portfolio, the Serum Institute remains focused on addressing emerging health challenges worldwide.
